Cancer genomic data sharing is a core pillar of precision oncology, underpinning reproducibility, scalability, and equity. The ability to discover, access, integrate, interpret, and reuse cancer 'omics data is a key determinant of precision oncology's value and benefit at scale. This work has been conducted as part of...
D. Torrents, Oliver Hofmann, Karen A. Cranston et al.· EBioMedicine· 1 citation
PURPOSE
Using real-world data (RWD), we assessed the impact of diagnostic regulatory pathways on activation timelines and biomarker testing implementation in biomarker-driven clinical trials across Europe.
METHODS
RWD from 132 Clinical Performance Study Applications (PSAs) and Ethics Committee (EC) submissions across...
Sarah Hersey, Haydar Çelik, Steven T. Rosen et al.· European Journal of Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.